newsfilter
← Latest News
PR Newswire·

Leap Therapeutics Reports Second Quarter 2024 Financial Results

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported...